Researcher Salvador Macip, an expert in the study of cancer and senescence, joins the Josep Carreras Leukaemia Research Institute to lead the “Mechanisms of Cancer and Ageing” group. Dr. Macip will collaborate with specialists in epigenetics and senescence at the Josep Carreras Institute and will keep his current affiliations as professor, researcher and Director of Health Sciences Studies at the Universitat Oberta de Catalunya and the University of Leicester (UK).
The Josep Carreras Leukaemia Research Institute (IJC), a CERCA center of the Generalitat de Catalunya, has a new laboratory led by researcher Salvador Macip in the framework of an institutional collaboration agreement between the Research Institute and the Universitat Oberta de Catalunya (UOC). This agreement strengthens the links and establishes a permanent framework for research collaboration between the two institutions.
The Catalan physician, scientist and writer will lead the “Mechanisms of Cancer and Ageing” group, which will study the mechanisms that determine resistance to treatment and relapse in B cell malignancies (especially Chronic Lymphocytic Leukemia and Diffuse Large B-cell Lymphoma) and the molecular pathways involved in age-related diseases, with particular emphasis on the role of senescent cells in cancer and ageing phenotypes. They also investigate prognostic/diagnostic markers of ageing and anti-senescent therapies for healthy ageing and as adjuvant treatments for leukemia.